Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1 1

Status

Terminated 3Completed 3Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 6Thoracic 4Other hematologic neoplasm 3Gynecologic 3Genitourinary 3Dermatologic 3Lymphoid 2Tumor-Agnostic 1Sarcoma 1Other neoplasm 1Myeloid 1CNS 1

Conditions

Skin Neoplasms 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Hodgkin Disease 1Cicatrix 1Breast Neoplasms 1

Interventions

pembrolizumab 58Ipilimumab 53Cyclophosphamide 53Nivolumab 45aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 19dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11spartalizumab 10Filgrastim 10Dacarbazine 10cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Sodium Chloride × Dermatologic × Clear all
NCT03432741 2025-05-26

Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Mayo Clinic

Phase 1 Terminated
17 enrolled
BreastDermatologicLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone

NCT03233828 2024-07-24

IL-2

Nova Scotia Health Authority

Phase 3 Terminated
1 enrolled 3 charts
Dermatologic

Melanoma

NCT01459666 2022-05-26

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

University Hospitals Cleveland Medical Center

Phase 4 Terminated
9 enrolled 6 charts
Dermatologic

Cicatrix, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡